1

Reduction of NO- and EDHF

-mediated vasodilatation in hypertension: role of asymmetr

ic dimethylarginine

Clin Exp Hypertens

2

Regulation by DDAH/ADMA

pathway of lipopolysaccharide-induced

tissue factor expression in endothelial cells..

Thromb Haemost

3

Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats.

Can J Physiol Pharmacol

4

Eur J Pharmacol

5

Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.

Eur J Pharmacol

6

Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation.

Biochem Biophys Res Commun

7

Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.

J Vasc Res

8

Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.

Life Sci

9

The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells.

Biochem Cell Biol

10

Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells.

Biochem Biophys Res Commun.

11

Biphasic effect of aspirin on apoptosis of bovine vascular endothelial cells and its molecular mechanism.

Acta Pharmacol Sin

12

Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.

Vascul Pharmacol

13

Down-regulation of endogenous nitric oxide synthase inhibitors on endothelial SK3 expression.

Vascul Pharmacol

14

Calcitonin Gene-Related Peptide-Mediated Depressor Effect and Inhibiting Vascular Hypertrophy of Rutaecarpine in Renovascular Hypertensive Rats.

J Cardiovasc Pharmacol

15

Asymmetric dimethylarginine reduced erthrocye deformability in streptozotocin-induced diabetic rat

Microvasc Res

16

Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.

J Cardiovasc Pharmacol

17

Brief small intestinal ischemia lessens renal ischemia-reperfusion injury rats..

Comp Med

18

P38 mitogen-activated protein kinase plays an inhititory role in hepatic lipogenesis.

J Biol Chem.

19

Prolinged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase.

J Biol Chem

熊燕(3)

20

Dimethylarginine dimethylaminohydrolase-2 genetransfer reverses endothelial dysfunction in aortas of dia-betic rats and high glucose treated-endothelial cells

Chinese J Pharmacol and Toxicology

21

Mitochondrial-derived ROS in edelfosine-induced apoptosis in yeasts and tumor cells

Acta Pharmacol Sin

22

Blockade of hypoxia-reoxygenation-mediated collagen type I expression and MMP activity by overexpression of TGF-beta1 delivered by AAV in mouse cardiomyocytes.

Am J Physiol Heart Circ Physiol.

23

Small Concentrations of oxLDL Induce Capillary Tube FORMATION From Endothelial Cells via LOX-1-Dependent Redox-Sensitive Pathway

24

LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion

25

氯沙坦通过下调单核细胞趋化蛋白1受体表达抑制单核细胞活化

中国动脉硬化杂志

26

银杏叶片干预对高血压患者生活质量的影响;

中国药房

27

降钙素基因相关肽和高血压研究进展

医学理论与实践

28

一氧化氮在中医药降压研究中的应用概况

湖南中医杂志

29

Cariporide对LPC诱导单核细胞与内皮细胞粘附及粘附分子表达的抑制作用

中国药理学通报

30

Cariporide对糖基化终末产物所致血管内皮损伤的保护作用

中南药学

31

卡托普利对对氧磷所致血管内皮损伤的保护作用及机制探讨

中南药学

32

对氧磷对血管内皮细胞的损伤作用及机制探讨

中国动脉硬化杂志

33

氟伐他汀对溶血性磷脂酰胆碱致动脉平滑肌细胞增殖和凋亡相关因子表达的影响

中国临床药理学与治疗学

34

缺血耐受的研究进展

中国动脉硬化杂志

35

葛根素对过氧化氢诱导平滑肌细胞凋亡的保护作用

中国医学工程

黎敏

方云祥

36

后适应对大鼠实验性局灶性脑缺血/再灌注损伤的保护作用

中国药理学通报

方芳

方云祥

37

PTE-ET-18-OCH_3诱导线粒体聚积并促发凋亡

湘南学院学报(医学版)

张辉

方云祥

38

氟伐他汀对溶血磷脂酰胆碱致内皮细胞粘附分子和基质金属蛋白酶-9表达的影响

中国临床药理学与治疗学

李健哲

方云祥

39

Edelfosine抑制S.pombe细胞分裂作用机制的研究

中国药理学通报

张  辉

方云祥

40

动脉粥样硬化的免疫调节与疫苗研制

中国药理学通报

41

后适应对大鼠脑缺血-再灌注损伤线粒体结构和功能的影响

中南药学

方  芳

方云祥

42

尼莫地平对过氧化氢诱导猪脑基底动脉氧化应激损伤的保护作用

中国临床药理学与治疗学

蔡志春

方云祥

43

脑缺血治疗药物研究的进展

中华神经医学

蔡志春

方云祥

44

p38丝裂原活化蛋白激酶在能量代谢控制和心血管疾病中的作用

威廉希尔williamhill官方网站学报(医学版)

45

罗格列酮对2型糖尿病大鼠肝线粒体功能障碍的影响

中南药学